The National Center for Policy Analysis is the latest group to weigh in on the subject of geographic variation in health spending, releasing a report detailing state-by-state cost differences. (NCPA Report) One way that they look at the analysis is health spending as a percent of a state’s economy. In this approach, Wyoming is the lowest, at about 8.86% of its GDP, with Virginia and Delaware also low. Maine is the highest at 21.7%, with West Virginia and Mississippi also very high. When you look only at Medicare spending, West Virginia remains high at 5.4% of state GDP, with Mississippi and Florida at about the same level. The low states are Alaska at about 1.1% and Wyoming and Colorado are also in that range. For Medicaid, Maine is the highest at 4.9% of state GDP and New York and Vermont are also at the top, while Nevada is the lowest in Medicaid at 1%, with Virginia and Colorado also at the bottom. There is a modest correlation between overall low or high spending and the same status for Medicare or Medicaid spending. The amount of total variation among states also has tended to stay the same over the last three decades, although variation in Medicaid spending has declined, probably due to nationalization of the program. On a per capita basis, there is also significant variation, with Massachusetts the highest at about $9278 per person and Utah the lowest at $5031. There is again a modest correlation between spending as a percent of state GDP and per capita spending. The same is true looking only at Medicare or Medicaid spending. What is useful to know is that on a per capita basis, the same states may have very different ranking for different payer types, so no universal statement can be made about why one state is higher or lower overall. Overall, a very complex picture of variation exists, one that cannot be easily explained as simply due to ineffective or inefficient care in high-spending states.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace